Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

40%(2 trials)

Phase Distribution

Ph phase_2

17%

Ph phase_4

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

Phase 4Post-market surveillance

2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(1)

Detailed Status

Completed5

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (33.3%)

Phase 42 (66.7%)

Trials by Status

withdrawn117%

completed583%

Recent Activity

0 active trials

Showing 5 of 6

completedphase_2

Maternal and Neonatal Outcomes Following Exposure to Benzodiazepines During Pregnancy

NCT04856436

withdrawnphase_4

Decreasing the Incidence of Delirium After Cardiac Surgery

NCT02119806

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT01391962Phase 2

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Completed

NCT02775864

Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia

Completed

NCT04622995

Benzodiazepines in Opiate Replacement Therapy

Completed

NCT04856436

Maternal and Neonatal Outcomes Following Exposure to Benzodiazepines During Pregnancy

Completed

NCT02119806Phase 4

Decreasing the Incidence of Delirium After Cardiac Surgery

Withdrawn

NCT01050478Phase 4

IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation

Completed

All 6 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 6